Medipattern has received FDA clearance for Visualize:Vascular, which is designed to quantify image data by segmenting and measuring regions of interest in vessels.

The software can help a physician assess vascular disease using ultrasound imaging, according to Toronto-based Medipattern. The technology is based on Medipattern’s Cadenza algorithm platform, expanding it from breast imaging to vascular imaging and incorporating 3D reconstruction of segmented regions of interest.

Visualize:Vascular is now available for sale in the U.S. First shipments are anticipated in the second quarter of this calendar year.